An angiotensin-converting enzyme inhibitor (ACE-I) reduces cardiac remodeling and a bradykinin B2 receptor (B2R) antagonist partially abolishes this ACE-I effect...
Keywords: B1 receptor, bradykinin, hypertension, MAP kinase, SHR-SP, TGF-?
02/2006 | Biological Chemistry, Walter de Gruyter